Overview

• The ROBIN test, developed by University of Nottingham and NUH scientists, delivers brain tumor diagnoses in under two hours during surgery.
• Trials on 50 patients showed a 100% diagnostic success rate, with full molecular profiling completed within 24 hours.
• The test combines multiple genetic analyses into a single nanopore-based assay, reducing costs to approximately £450 per patient.
• Researchers aim to roll out the technology across NHS Trusts within the next year to improve access and accelerate treatment pathways.
• The rapid diagnosis reduces patient anxiety, informs surgical strategies in real-time, and ensures faster initiation of therapies like chemotherapy and radiotherapy.